Nusinersen Sodium is an antisense oligonucleotide indicated for the treatment of spinal muscular atrophy. This medication functions by modulating the splicing of the SMN2 gene to increase the expression… Read more
Nusinersen Sodium is an antisense oligonucleotide indicated for the treatment of spinal muscular atrophy. This medication functions by modulating the splicing of the SMN2 gene to increase the expression of survival motor neuron protein. In pharmaceutical analytical environments, the accurate characterization of this complex therapeutic requires a comprehensive suite of analytical tools. Reference standards, including impurity standards and stable isotope-labelled compounds, are essential for rigorous impurity profiling, method validation, and quality control. Laboratories utilize these high-quality materials to support development and stability testing, particularly when using advanced techniques such as liquid chromatography-mass spectrometry to resolve closely related degradation products, truncation sequences, and modification variants. By providing well-characterized reference materials, this category supports the precise quantification and verification of drug substance identity and purity, ensuring the robustness of analytical workflows in compliance with regulatory standards for oligonucleotide therapeutics.